HISTIDE
Histide is a biotech intellectual property platform company pioneering a new class of non-mutagenic extracellular therapeutic agents called Cell Recoding Molecules™ (CRMs). This innovative platform builds on Histide’s expertise in the mechanisms underlying the cell’s microenvironmental sensing and signal transduction processes. The CRMs promote and stimulate the cell’s natural capacities to redirect its own fate by integrating accurate extracellular signals. This is at the heart of Histi... de’s groundbreaking approach of addressing diseases called Recoding Therapeutics™, that goes beyond traditional cell, gene or RNA based therapies. Histide has a technological breakthrough with vast indication spectra of pharmaceuticals, medical devices and medical cosmetics. Their mission : Establish Cell Recoding Molecules (CRMs) as new class of therapeutic solutions. Their vision : To unlock the potential of Recoding Therapeutics by establishing an ecosystem of teams and partners, all committed to providing enhanced therapeutic solutions across diverse areas and routes of administration, for diseases that are untreatable or undruggable today.
HISTIDE
Social Links:
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2014-01-01
Address:
Schindellegi, Schwyz, Switzerland
Country:
Switzerland
Website Url:
http://www.histide.com
Total Employee:
11+
Status:
Active
Contact:
+41 43 888 2577
Email Addresses:
[email protected]
Total Funding:
4.5 M CHF
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Google Universal Analytics Font Awesome Apache
Similar Organizations
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Calimmune
Calimmune is a clinical-stage gene therapy company.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Theolytics
Theolytics is a pre-clinical stage biotechnology company developing next-generation oncolytic viral therapies.
Current Advisors List
Current Employees Featured
Founder
Investors List
Partner Capital
Partner Capital investment in Series A - Histide
Official Site Inspections
http://www.histide.com
- Host name: cluster014.ovh.net
- IP address: 213.186.33.87
- Location: Saran France
- Latitude: 47.9531
- Longitude: 1.871
- Timezone: Europe/Paris
- Postal: 45770
More informations about "Histide"
Histide
Histideâ„¢ s a biotech intellectual property platform company pioneering a new class of non-mutagenic extracellular therapeutic agents called Cell Recoding Moleculesâ„¢ (CRM). This innovative platform builds on Histide’s expertise in …See details»
Histide - Crunchbase Company Profile & Funding
Histide is a biotech intellectual property platform company pioneering a new class of non-mutagenic extracellular therapeutic agents called Cell Recoding …See details»
Histide - LinkedIn
Histideâ„¢ is pioneering Recoding Therapeuticsâ„¢, a novel therapy using non-mutagenic extracellular technologies to direct cell fate. Based on the universal understanding of the mechanisms ...See details»
Histide Company Profile 2024: Valuation, Funding & Investors
Histide has 14 total employees. What industry is Histide in? Histide’s primary industry is Biotechnology. Is Histide a private or public company? Histide is a Private company. What is …See details»
Histide Company Profile - Office Locations, Competitors ... - Craft
Histide has 5 employees across 2 locations. See insights on Histide including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Histide AG - Schindellegi, Switzerland - bionity.com
Histideâ„¢ is pioneering Recoding Therapeuticsâ„¢, a novel therapy using non-mutagenic extracellular technologies to direct cell fate. Based on the universal understanding of the …See details»
Histide AG - VentureRadar
Histide’s pipeline of investigational Recoding therapeutics is focused in 5 Strategic Therapeutic Areas: Oncology, with a pipeline of CRMs that trigger the tumor cells to switch to healthy cells; …See details»
Histide - Products, Competitors, Financials, Employees, …
Histide has launched several preclinical programs in pharma and medical device indications. About Histide AG Histideâ„¢ is a biotech intellectual property platform company pioneering a …See details»
Histide - Company Profile - Tracxn
Histide - Biotechnology startup developing novel therapeutics and cosmetics based on proprietary Cell Recoding platform. Raised a total funding of $4.6M over 1 round from 2 investors. …See details»
Romain Julia - Founder @ Histide - Crunchbase Person Profile
Primary Organization . Histide . Location Zürich, Zurich, Switzerland; Regions Europe, Middle East, and Africa (EMEA) ... Prior to founding Histide with Dr. OF. Zouani,Julia acquired more …See details»
Nextsource | Company Profile | Histide
Explore the company profile of Histide (histide.com) featuring business details and insights, funding data, industry info, employee numbers, and more.See details»
Histide | EU-Startups
Histide is a biotech intellectual property platform company pioneering a new class of non-mutagenic extracellular therapeutic agents called Cell Recoding Moleculesâ„¢ (CRMs). This …See details»
Chief Intellectual Property Officer at Histide - The Org
Finally, they joined Histide in 2015, where they have served as Chief Intellectual Property Officer, Vice-Chairman of the Board of Directors, Member of the Board of Directors, and IP and Legal …See details»
Histide AG - Drug pipelines, Patents, Clinical trials - Synapse
100 Translational Medicine associated with Histide AG. Login to view more data. Corporation Tree. Boost your research with our corporation tree data. login. or. view full example data. …See details»
www.histide.com Histide introduces Cell Recoding Molecules as a …
Histide’s Cell Recoding Molecules provide a diverse source of nonmutagenic extracellular therapeutic agents for tissue regeneration and disease healing. H istide is a Swiss biotech andSee details»
Histide AG - startup.ch
Histide is pioneering Recoding Therapeuticsâ„¢, a novel therapy using non-mutagenic extracellular technologies to direct cell fate. Based on the universal understanding of the mechanisms …See details»
Histide Raises CHF 4.5 M (USD 4.6 M) Series A ... - Business Wire
Nov 10, 2014 Histide Raises CHF 4.5 M (USD 4.6 M) Series A Investment Round to Advance Its Pioneering Recoding Therapeuticsâ„¢ Technology November 10, 2014 11:29 AM Eastern …See details»
Histide Announces Publication in Nature Materials Revealing …
Dec 2, 2015 Histideâ„¢ is a biotech intellectual property platform company pioneering a new class of nonmutagenic extracellular therapeutic agents called Cell Recoding Moleculesâ„¢ (CRMs). …See details»
Histide Reviews | Read Client Reviews of Histide. - trustburn.com
Read reviews of Histide. Write and share your personal story. Your experience will help others make the right buying decision. Trustburn. Categories Log in For business. Search. …See details»